HONG KHOEUR: Open Payments
NPI 1366514606 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,379 in 64 payments from 14 companies in 2025. Trend: 2023 $3,166 · 2024 $2,431 · 2025 $2,379
Food & beverage: $2,379
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $462 |
| AstraZeneca Pharmaceuticals LP | 9 | $420 |
| Lilly USA, LLC | 6 | $308 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $266 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $175 |
| Corcept Therapeutics | 3 | $165 |
| Novo Nordisk Inc | 2 | $160 |
| PFIZER INC. | 2 | $146 |
| Regeneron Healthcare Solutions, Inc. | 3 | $99 |
| Viatris Specialty LLC | 3 | $81 |
Products named: OTEZLA, Kerendia, AIRSUPRA, ISTURISA, Korlym, MOUNJARO, NURTEC ODT, BREZTRI.
Industry payments across CA — which companies pay providers there.
